This inventor holds 5 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 1990-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 2,198 
1 out of 834,513 Years Active: 1990-2002
Title: The Innovative Contributions of Joseph W. Venslavsky
Introduction
Joseph W. Venslavsky is a notable inventor based in Wayne, Pennsylvania, who has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has focused on developing methods and compounds that address critical health issues.
Latest Patents
Among his latest patents is a method for treating CCR5-mediated disease states in mammals. This method involves administering an effective amount of a specific compound or its pharmaceutically acceptable salt to a mammal in need of treatment. Another significant invention by Venslavsky involves fibrinogen receptor antagonists, which are compounds designed to inhibit platelet aggregation. This invention includes pharmaceutical compositions that effectively achieve this activity.
Career Highlights
Throughout his career, Venslavsky has worked with prominent organizations, including SmithKline Beecham Corporation. His work has contributed to advancements in medical treatments and pharmaceutical innovations.
Collaborations
Venslavsky has collaborated with notable individuals in his field, including William Edward Bondinell and Robert M. DeMarinis. Their combined expertise has likely enhanced the impact of their innovations.
Conclusion
Joseph W. Venslavsky's contributions to pharmaceutical inventions demonstrate his commitment to improving health outcomes through innovative methods and compounds. His work continues to influence the field and inspire future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile